Verily acquires SignalPath; Biden pushes for lower drug prices
This week's top stories include Verily beefing up its clinical trial platform, President Biden pushing for lower drug prices in his $3.5 trillion budget proposal, and the launch of the Teleprimary Care Certificate program.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Patient Engagement
Patient Engagement
Financial/Revenue Cycle Management
Webinars
Artificial Intelligence